
Gelatti 01262023 L3 Lab Sample
About
Gelatti 01262023 L3 Lab Sample is a hybrid cannabis strain. Lab samples test between 23.2% and 31.5% THC, with caryophyllene (0.91%) as the dominant terpene.
Why does Gelatti 01262023 L3 Lab Sample feel pain-relieving?
Gelatti 01262023 L3 Lab Sample's pain-relieving effects are linked to its dominant caryophyllene (0.91%), one of the few terpenes that binds directly to CB2 cannabinoid receptors. Complemented by limonene (0.51%), known for mood elevation and stress relief.
Strain Profile
May Help With
Caryophyllene has strong anti-inflammatory properties
Caryophyllene binds to CB2 receptors for pain relief
Linalool has calming, stress-relieving properties
Linalool is known for anti-anxiety effects
Based on terpene research and reported effects. Not medical advice. Consult a healthcare professional for medical decisions.
Similar Strains
Strains with a similar profile you might enjoy
Quick Info
- Type
- hybrid
- Breeder
- Not verified
- THC
- 23.2–31.5%
- Chemotype
- Caryophyllene-dominant
What is Caryophyllene?
Spicy, peppery terpene found in black pepper, cloves, and cinnamon.
Learn more →
← Back to all strainsAbout Gelatti 01262023 L3 Lab Sample
- Gelatti 01262023 L3 Lab Sample is a hybrid cannabis strain. Hybrids combine characteristics of both indica and sativa genetics.
- Gelatti 01262023 L3 Lab Sample typically tests at 23.2% to 31.5% THC. This is considered a high-potency strain, so start with a low dose if you are new to it.
- The dominant terpenes in Gelatti 01262023 L3 Lab Sample are Caryophyllene, Limonene, Humulene. Terpenes influence the aroma, flavor, and effects of a cannabis strain.
